Innovation versus Financialization in the US Pharmaceutical Industry
Forventes utgitt
Forventes utgitt: 31.10.2025
Leveringstid: 3-10 dager
Handlinger
Beskrivelse
Omtale
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'
Andre bøker i samme serie
Regulating EU Sustainability Reporting : Learning from Failure and Success
9781009737128 Elements in Corporate Governance Innbundet
31.10.2025
Engelsk
Forventes utgitt
Incorporating Purpose : The New Legal Foundations for the Corporation and its Management
9781009623490 Elements in Corporate Governance Innbundet
06.03.2025
Engelsk
Produseres på bestilling
The Rhetoric and Reality of Shareholder Democracy and Hedge-Fund Activism
9781009576413 Elements in Corporate Governance Innbundet
09.01.2025
Engelsk
Produseres på bestilling
Andre bøker av samme forfatter
Innovation versus Financialization in the US Pharmaceutical Industry
9781009707985 Elements in Corporate Governance Heftet
31.10.2025
Engelsk
Forventes utgitt
From Financialisation to Innovation in UK Big Pharma : AstraZeneca and GlaxoSmithKline
9781009278164 Elements in Reinventing Capitalism Heftet
22.12.2022
Engelsk
Produseres på bestilling